Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study

Medicin og biovidenskab

• Septal Occluder Device 100%
• Patent Foramen Ovale 90%
• Brain Infarction 89%
• Clinical Studies 48%
• Stroke 47%
• Neuroimaging 15%
• Therapeutics 11%
• Platelet Aggregation Inhibitors 9%
• Random Allocation 8%
• Secondary Prevention 8%
• Population 6%
• Health Care Outcome Assessment 5%
• Clinical Trials 5%
• Incidence 4%